Liver transplantation for unresectable perihilar cholangiocarcinoma

Julie K. Heimbach, Gregory James Gores, Michael Haddock, Steven Robert Alberts, Scott Nyberg, Michael B. Ishitani, Charles B. Rosen

Research output: Contribution to journalArticle

152 Citations (Scopus)

Abstract

Patients with unresectable, stage I and II perihilar cholangiocarcinoma were treated with neoadjuvant external beam irradiation, brachytherapy, and 5-fluorouracil and/or oral capecitabine prior to liver transplantation. Fifty-six patients underwent treatment between 1993 and 2003. Four patients died and 4 had disease progression prior to completion of neoadjuvant therapy. Forty-eight patients underwent operative staging and 14 had findings precluding transplantation. Twenty-eight patients underwent transplantation and 6 patients are awaiting transplantation. Three patients died from perioperative complications, and 4 developed recurrent disease 22 to 63 months after transplantation. Actuarial patient survival was 54% at 5 years for all 56 patients, 64% for 48 operatively staged patients, and 84% for 34 patients with negative staging operations. Actuarial survival was 88% at 1 year and 82% 5 years after transplantation. Neoadjuvant chemoradiotherapy with liver transplantation achieves excellent results for patients with localized, regional lymph node negative, hilar cholangiocarcinoma.

Original languageEnglish (US)
Pages (from-to)201-207
Number of pages7
JournalSeminars in Liver Disease
Volume24
Issue number2
DOIs
StatePublished - May 2004

Fingerprint

Klatskin Tumor
Liver Transplantation
Transplantation
Neoadjuvant Therapy
Survival
Brachytherapy
Chemoradiotherapy

Keywords

  • Cholangiocarcinoma
  • Liver transplantation
  • Neoadjuvant therapy

ASJC Scopus subject areas

  • Hepatology

Cite this

Liver transplantation for unresectable perihilar cholangiocarcinoma. / Heimbach, Julie K.; Gores, Gregory James; Haddock, Michael; Alberts, Steven Robert; Nyberg, Scott; Ishitani, Michael B.; Rosen, Charles B.

In: Seminars in Liver Disease, Vol. 24, No. 2, 05.2004, p. 201-207.

Research output: Contribution to journalArticle

@article{65f2b78a772d4ff98fad8ff2e6bb3fa2,
title = "Liver transplantation for unresectable perihilar cholangiocarcinoma",
abstract = "Patients with unresectable, stage I and II perihilar cholangiocarcinoma were treated with neoadjuvant external beam irradiation, brachytherapy, and 5-fluorouracil and/or oral capecitabine prior to liver transplantation. Fifty-six patients underwent treatment between 1993 and 2003. Four patients died and 4 had disease progression prior to completion of neoadjuvant therapy. Forty-eight patients underwent operative staging and 14 had findings precluding transplantation. Twenty-eight patients underwent transplantation and 6 patients are awaiting transplantation. Three patients died from perioperative complications, and 4 developed recurrent disease 22 to 63 months after transplantation. Actuarial patient survival was 54{\%} at 5 years for all 56 patients, 64{\%} for 48 operatively staged patients, and 84{\%} for 34 patients with negative staging operations. Actuarial survival was 88{\%} at 1 year and 82{\%} 5 years after transplantation. Neoadjuvant chemoradiotherapy with liver transplantation achieves excellent results for patients with localized, regional lymph node negative, hilar cholangiocarcinoma.",
keywords = "Cholangiocarcinoma, Liver transplantation, Neoadjuvant therapy",
author = "Heimbach, {Julie K.} and Gores, {Gregory James} and Michael Haddock and Alberts, {Steven Robert} and Scott Nyberg and Ishitani, {Michael B.} and Rosen, {Charles B.}",
year = "2004",
month = "5",
doi = "10.1055/s-2004-828896",
language = "English (US)",
volume = "24",
pages = "201--207",
journal = "Seminars in Liver Disease",
issn = "0272-8087",
publisher = "Thieme Medical Publishers",
number = "2",

}

TY - JOUR

T1 - Liver transplantation for unresectable perihilar cholangiocarcinoma

AU - Heimbach, Julie K.

AU - Gores, Gregory James

AU - Haddock, Michael

AU - Alberts, Steven Robert

AU - Nyberg, Scott

AU - Ishitani, Michael B.

AU - Rosen, Charles B.

PY - 2004/5

Y1 - 2004/5

N2 - Patients with unresectable, stage I and II perihilar cholangiocarcinoma were treated with neoadjuvant external beam irradiation, brachytherapy, and 5-fluorouracil and/or oral capecitabine prior to liver transplantation. Fifty-six patients underwent treatment between 1993 and 2003. Four patients died and 4 had disease progression prior to completion of neoadjuvant therapy. Forty-eight patients underwent operative staging and 14 had findings precluding transplantation. Twenty-eight patients underwent transplantation and 6 patients are awaiting transplantation. Three patients died from perioperative complications, and 4 developed recurrent disease 22 to 63 months after transplantation. Actuarial patient survival was 54% at 5 years for all 56 patients, 64% for 48 operatively staged patients, and 84% for 34 patients with negative staging operations. Actuarial survival was 88% at 1 year and 82% 5 years after transplantation. Neoadjuvant chemoradiotherapy with liver transplantation achieves excellent results for patients with localized, regional lymph node negative, hilar cholangiocarcinoma.

AB - Patients with unresectable, stage I and II perihilar cholangiocarcinoma were treated with neoadjuvant external beam irradiation, brachytherapy, and 5-fluorouracil and/or oral capecitabine prior to liver transplantation. Fifty-six patients underwent treatment between 1993 and 2003. Four patients died and 4 had disease progression prior to completion of neoadjuvant therapy. Forty-eight patients underwent operative staging and 14 had findings precluding transplantation. Twenty-eight patients underwent transplantation and 6 patients are awaiting transplantation. Three patients died from perioperative complications, and 4 developed recurrent disease 22 to 63 months after transplantation. Actuarial patient survival was 54% at 5 years for all 56 patients, 64% for 48 operatively staged patients, and 84% for 34 patients with negative staging operations. Actuarial survival was 88% at 1 year and 82% 5 years after transplantation. Neoadjuvant chemoradiotherapy with liver transplantation achieves excellent results for patients with localized, regional lymph node negative, hilar cholangiocarcinoma.

KW - Cholangiocarcinoma

KW - Liver transplantation

KW - Neoadjuvant therapy

UR - http://www.scopus.com/inward/record.url?scp=2942568143&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2942568143&partnerID=8YFLogxK

U2 - 10.1055/s-2004-828896

DO - 10.1055/s-2004-828896

M3 - Article

C2 - 15192792

AN - SCOPUS:2942568143

VL - 24

SP - 201

EP - 207

JO - Seminars in Liver Disease

JF - Seminars in Liver Disease

SN - 0272-8087

IS - 2

ER -